Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Mirella Mashiach
Mirella is a former big pharma executive and biotech investor. She was the Managing Director of the $200M corporate venture biotech fund at Teva Pharmaceuticals and its VP of BD and Strategy. Prior to that, Mirella was an attorney at Dentons, where she focused on intellectual property and corporate and commercial deals in life sciences.
Companies & Work
Output Biosciences
Output Biosciences is pioneering Biologically-Aware Generative AI to finally understand complex biological systems. Our new generative AI architecture can handle the extremely long, nonlinear, fragmented, and high dimensional data of biological systems. We are building Large Biological Models that can generate breakthrough medicines and transform the way we diagnose, treat and prevent disease.
